Evidence map›Paper›PMID 15890081›Full record

ArticleVirology journal2005

Development and characterization of positively selected brain-adapted SIV.

Peter J Gaskill, Debbie D Watry, Tricia H Burdo, Howard S Fox

Abstract read
In one paragraph

Article in Virology journal, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2006
    Review
  9. Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peter J GaskillDepartment of Neuropharmacology, The Scripps Research Institute, 10550 N, Torrey Pines Road, La Jolla, CA 92037, USA. walkin@scripps.edu
Debbie D Watry
Tricia H Burdo
Howard S Fox

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007606 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1999 to 2013
$2.1M
PERIPHERAL VIRAL LOAD AND SIV-INDUCED CNS DYSFUNCTIONR01MH059468 · NIMH · SCRIPPS RESEARCH INSTITUTE · PI FOX, HOWARD S. · 1999 to 2003
$2.1M
Monocyte/Macrophages in neuroAIDSR01NS045534 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI FOX, HOWARD S. · 2003 to 2006
$1.8M
NIAID NIH HHS T32 AI007606NIAID NIH HHS T32 AI07606NIMH NIH HHS P30 MH062261NIMH NIH HHS P30 MH62261NIMH NIH HHS R01 MH059468NIMH NIH HHS R01 MH59468NINDS NIH HHS R01 NS045534
6 · The paper itself

Abstract

HIV is found in the brains of most infected individuals but only 30% develop neurological disease. Both viral and host factors are thought to contribute to the motor and cognitive disorders resulting from HIV infection. Here, using the SIV/rhesus monkey system, we characterize the salient characteristics of the virus from the brain of animals with neuropathological disorders. Nine unique molecular clones of SIV were derived from virus released by microglia cultured from the brains of two macaques with SIV encephalitis. Sequence analysis revealed a remarkably high level of similarity between their env and nef genes as well as their 3' LTR. As this genotype was found in the brains of two separate animals, and it encoded a set of distinct amino acid changes from the infecting virus, it demonstrates the convergent evolution of the virus to a unique brain-adapted genotype. This genotype was distinct from other macrophage-tropic and neurovirulent strains of SIV. Functional characterization of virus derived from representative clones showed a robust in vitro infection of 174xCEM cells, primary macrophages and primary microglia. The infectious phenotype of this virus is distinct from that shown by other strains of SIV, potentially reflecting the method by which the virus successfully infiltrates and infects the CNS. Positive in vivo selection of a brain-adapted strain of SIV resulted in a near-homogeneous strain of virus with distinct properties that may give clues to the viral basis of neuroAIDS.

Indexed as

Amino Acid SequenceAnimalsBrainCloning, MolecularCytopathogenic Effect, ViralGene Expression Regulation, ViralMacaca mulattaMacrophagesMicrogliaMolecular Sequence DataSimian Immunodeficiency VirusViral Regulatory and Accessory ProteinsNEF protein, SIVViral Regulatory and Accessory Proteins

Identifiers

PMID15890081
PMCPMC1145188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.